Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120.

Although many antigen sequences potentially can bind to the MHCII proteins, only a small number of epitopes dominate the immune response. Additional mechanisms of processing, presentation or recognition must restrict the immune response against a large portion of the antigen. A highly significant correlation is found between epitope immunodominance and local structural stability in hen egg lysozyme. Since antigen proteins are likely to retain substantial native-like structure in the processing compartment, protease action may be focused on regions that are most readily accommodated in the protease active sites, and thus, the intervening sequence are preferentially presented. Immunodominance also correlates with sequence conservation as expected from the constraints imposed by structure. These results suggest that the three-dimensional structure of the antigen limits the immune response against some antigen segments. For HIV gp120, a substantial improvement in the accuracy of epitope prediction is obtained by combining rules for MHCII binding with a restriction of the predicted epitopes to well-conserved sequences.

[1]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[2]  S. Landry,et al.  Local protein instability predictive of helper T-cell epitopes. , 1997, Immunology today.

[3]  A. D. De Groot,et al.  An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. , 1997, AIDS research and human retroviruses.

[4]  N. Letvin,et al.  HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. , 1997, Journal of immunology.

[5]  D. Turk,et al.  Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. , 1997, Biological chemistry.

[6]  G. Hämmerling,et al.  Editing of the HLA‐DR‐peptide repertoire by HLA‐DM. , 1996, The EMBO journal.

[7]  B. Evavold,et al.  Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.

[8]  V. Turk,et al.  Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L , 1996, The Journal of experimental medicine.

[9]  E. Sercarz,et al.  Antigen processing and T cell repertoires as crucial aleatory features in induction of autoimmunity. , 1996, Journal of autoimmunity.

[10]  J. Hansen,et al.  Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems. , 1996, Vaccine.

[11]  D. Wiley,et al.  Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. F. Naujokas,et al.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Kageyama,et al.  Processing of the Precursors to Neurotensin and Other Bioactive Peptides by Cathepsin E (*) , 1995, The Journal of Biological Chemistry.

[14]  T. Sosnick,et al.  Protein folding intermediates: native-state hydrogen exchange. , 1995, Science.

[15]  A. Lanzavecchia,et al.  Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants , 1995, The Journal of experimental medicine.

[16]  E. Unanue,et al.  Identification of a major I-Ek-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[18]  Emil R. Unanue,et al.  Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell , 1994, Nature.

[19]  Y. Loh,et al.  In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3). , 1994, Endocrinology.

[20]  J. Strominger,et al.  Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH , 1994, The Journal of experimental medicine.

[21]  R. Walsky,et al.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J M Thornton,et al.  Modeling studies of the change in conformation required for cleavage of limited proteolytic sites , 1994, Protein science : a publication of the Protein Society.

[23]  M. Satoh,et al.  Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen , 1994, The Journal of experimental medicine.

[24]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[25]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[26]  C. Dobson,et al.  Hydrogen exchange in native and denatured states of hen egg‐white lysozyme , 1992, Proteins.

[27]  S. Buus,et al.  MHC molecules protect T cell epitopes against proteolytic destruction. , 1992, Journal of immunology.

[28]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[29]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[30]  R. Rappuoli,et al.  Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[32]  H. Kalbacher,et al.  Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets. , 1991, Biochemistry.

[33]  K. Rock,et al.  The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. , 1991, Journal of immunology.

[34]  J M Thornton,et al.  Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. , 1991, Journal of molecular biology.

[35]  J. Rothbard,et al.  Conformational and structural characteristics of peptides binding to HLA-DR molecules. , 1991, Journal of immunology.

[36]  A. Witkowski,et al.  Structural organization of the multifunctional animal fatty-acid synthase. , 1991, European journal of biochemistry.

[37]  E. Sercarz,et al.  T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes , 1991, The Journal of experimental medicine.

[38]  M. Vas,et al.  Reactivation of 3-phosphoglycerate kinase from its unfolded proteolytic fragments. , 1990, European journal of biochemistry.

[39]  G. Clements,et al.  A chink in HIV's armour? , 1990, Nature.

[40]  H. Kirschke,et al.  The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B. , 1989, The Biochemical journal.

[41]  L. Kay,et al.  Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. , 1989, Biochemistry.

[42]  Y. Paterson,et al.  Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations , 1989, The Journal of experimental medicine.

[43]  C. DeLisi,et al.  T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction. , 1989, International immunology.

[44]  K. Cease,et al.  Identification of proteases that process distinct epitopes on the same protein. , 1989, Journal of immunology.

[45]  D. Richman,et al.  T cell recognition of HIV synthetic peptides in a natural infection. , 1989, Journal of immunology.

[46]  P. Allen,et al.  Binding to Ia protects an immunogenic peptide from proteolytic degradation. , 1989, Journal of immunology.

[47]  H. Jörnvall,et al.  95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Eric O Long,et al.  Structural model of HLA-DR1 restricted T cell antigen recognition , 1988, Cell.

[49]  W. Taylor,et al.  A sequence pattern common to T cell epitopes. , 1988, The EMBO journal.

[50]  R. Bruccoleri,et al.  Correlation among sites of limited proteolysis, enzyme accessibility and segmental mobility , 1987, FEBS letters.

[51]  F M Richards,et al.  Crystal structure of hen egg-white lysozyme at a hydrostatic pressure of 1000 atmospheres. , 1987, Journal of molecular biology.

[52]  C DeLisi,et al.  T-cell antigenic sites tend to be amphipathic structures. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Barrett,et al.  Action of human liver cathepsin B on the oxidized insulin B chain. , 1983, The Biochemical journal.

[54]  M. Goldberg,et al.  Isolation and characterization of independently folding regions of the beta chain of Escherichia coli tryptophan synthetase. , 1977, Biochemistry.

[55]  Van Regenmortel,et al.  Structure of antigens , 1992 .

[56]  E. Sandström,et al.  HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. , 1989, Journal of acquired immune deficiency syndromes.

[57]  C. Fathman,et al.  The structure of T-cell epitopes. , 1987, Annual review of immunology.

[58]  Dagmar Ringe,et al.  [19]Study of protein dynamics by X-ray diffraction , 1986 .

[59]  F. Celada,et al.  Constraints in T‐B cooperation related to epitope topology on E. coli β‐galactosidase. I. The fine specificity of T cells dictates the fine specificity of antibodies directed to conformation‐ dependent determinants , 1985, European journal of immunology.

[60]  N. Katunuma,et al.  Selective cleavage of peptide bonds by cathepsins L and B from rat liver. , 1983, Journal of biochemistry.